Polycythemia vera: Updated Onkopedia Guidelines recommend Interferon alfa as preferred First-line Treatment

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2024年 / 47卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] First-line treatment of FELV and FIV in the clinical stages -: Interferon
    Vandaële, E
    POINT VETERINAIRE, 2004, 35 (248): : 14 - 15
  • [22] The Updated NICE Guidelines: Cardiac CT as the First-Line Test for Coronary Artery Disease
    Moss A.J.
    Williams M.C.
    Newby D.E.
    Nicol E.D.
    Current Cardiovascular Imaging Reports, 2017, 10 (5)
  • [23] Economic evaluation of sunitinib vs. interferon-alfa (IFN-alfa) in first-line treatment of Metastatic Renal Cell Carcinoma (MRCC) in Colombia
    Godoy, J., I
    Cardona, A. F.
    Alvis, N.
    Arango, C. H.
    Romero, M.
    Spath, A.
    Ramirez, P.
    Caceres, H. A.
    Quijano, M. F.
    VALUE IN HEALTH, 2008, 11 (03) : A100 - A100
  • [24] When to recommend and to pay for first-line adjuvant breast cancer treatment? A structured review of the literature
    Kilian, R
    Porzsolt, F
    BREAST, 2005, 14 (06): : 636 - 642
  • [25] COST-EFFECTIVENESS ANALYSIS OF SUNITINIB VERSUS INTERFERON ALFA FOR THE FIRST-LINE TREATMENT OF ADVANCED AND/OR METASTATIC RENAL CELL CARCINOMA IN SINGAPORE
    Pruis, S.
    Pearce, F.
    Aziz, Abdul M., I
    Wu, D. B.
    Ng, K. H.
    VALUE IN HEALTH, 2018, 21 : S15 - S15
  • [26] Interferon Alfa as a First- and Second-Line Treatment Option for Primary Myelofibrosis
    Sghibneva-Bobeico, Nina
    Musteata, Vasile
    Robu, Maria
    Covalschi, Elena
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S391 - S391
  • [27] OVERALL SURVIVAL WITH SUNITINIB VERSUS INTERFERON-ALFA (IFN-□) AS FIRST-LINE TREATMENT FOR METASTATIC RENAL CELL CARCINOMA (MRCC)
    Szczylik, C.
    Negrier, S.
    Oudard, S.
    Figlin, R. A.
    Hutson, T. E.
    Tomczak, P.
    Michaelson, M. D.
    Bukowski, R. M.
    Huang, X.
    Kim, S. T.
    Chen, I
    Motzer, R. J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 182 - 182
  • [28] Combination therapy is preferred for the first-line treatment of hypertension in high-risk patients
    Drugs & Therapy Perspectives, 2010, 26 (7) : 17 - 20
  • [29] Interferon-α as first-line therapy for treatment of multicentric Castleman's disease
    Andrès, E
    Maloisel, F
    ANNALS OF ONCOLOGY, 2000, 11 (12) : 1613 - 1614
  • [30] Sunitinib versus interferon-α for first-line treatment of metastatic renal cell carcinoma:: Updated results and further prognostic factor analyses
    Gruenwald, V.
    Eberhardt, W.
    Ringhoffer, M.
    Jakse, G.
    Motzer, R. J.
    ONKOLOGIE, 2008, 31 : 179 - 179
12345